Enhanced dissolution and bioavailability of revaprazan using self-nanoemulsifying drug delivery system
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Goo, Yoon Tae | - |
dc.contributor.author | Sa, Cheol-Ki | - |
dc.contributor.author | Kim, Min Song | - |
dc.contributor.author | Sin, Gi Hyeong | - |
dc.contributor.author | Kim, Chang Hyun | - |
dc.contributor.author | Kim, Hyeon Kyun | - |
dc.contributor.author | Kang, Myung Joo | - |
dc.contributor.author | Lee, Sangkil | - |
dc.contributor.author | Choi, Young Wook | - |
dc.date.accessioned | 2022-05-26T01:40:09Z | - |
dc.date.available | 2022-05-26T01:40:09Z | - |
dc.date.issued | 2022-04 | - |
dc.identifier.issn | 1083-7450 | - |
dc.identifier.issn | 1097-9867 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/58060 | - |
dc.description.abstract | A self-nanoemulsifying drug delivery system (SNEDDS) was developed to enhance the dissolution and oral bioavailability (BA) of revaprazan (RVP). Various SNEDDSs containing 200 mg of RVP were formulated using Capmul MCM, Tween 80, and Brij L4, and they were characterized according to their size, polydispersity index, and dissolution behavior. Dissolution rates of all SNEDDS formulations significantly (p < 0.05) improved with the formation of nanoemulsion with monodispersity. Formulation D resulted in RVP dissolution exceeding 70% at 2 h. Compared to raw RVP, SNEDDS exhibited a 4.8- to 7.4-fold improved effective permeability coefficient (P-eff) throughout the intestine in the in situ single pass intestinal permeability study and a 5.1-fold increased oral BA in the in vivo oral absorption assessment in rats. To evaluate the degree of lymphatic uptake, cycloheximide (CYC), a chylomicron flowing blocker, was pretreated prior to the experiment. This pretreatment barely affected the absorption of raw RVP; however, it greatly influenced the absorption of SNEDDS, resulting in an approximately 40% reduction in both the P-eff value and oral BA representing lymphatic transport. Thus, we suggest that the SNEDDS formulation is a good candidate for improving oral absorption of RVP through enhanced lymphatic uptake. | - |
dc.format.extent | 11 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | TAYLOR & FRANCIS LTD | - |
dc.title | Enhanced dissolution and bioavailability of revaprazan using self-nanoemulsifying drug delivery system | - |
dc.type | Article | - |
dc.identifier.doi | 10.1080/10837450.2022.2070644 | - |
dc.identifier.bibliographicCitation | PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, v.27, no.4, pp 414 - 424 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000791161900001 | - |
dc.identifier.scopusid | 2-s2.0-85132455063 | - |
dc.citation.endPage | 424 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 414 | - |
dc.citation.title | PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY | - |
dc.citation.volume | 27 | - |
dc.type.docType | Article | - |
dc.publisher.location | 영국 | - |
dc.subject.keywordAuthor | Self-nanoemulsifying drug delivery system | - |
dc.subject.keywordAuthor | revaprazan | - |
dc.subject.keywordAuthor | oral bioavailability | - |
dc.subject.keywordAuthor | lymphatic transport | - |
dc.subject.keywordAuthor | cycloheximide | - |
dc.subject.keywordPlus | INTESTINAL LYMPHATIC TRANSPORT | - |
dc.subject.keywordPlus | SOLID LIPID NANOPARTICLES | - |
dc.subject.keywordPlus | FLOW BLOCKING APPROACH | - |
dc.subject.keywordPlus | ORAL BIOAVAILABILITY | - |
dc.subject.keywordPlus | PHYSICOCHEMICAL CHARACTERIZATION | - |
dc.subject.keywordPlus | IN-SITU | - |
dc.subject.keywordPlus | ABSORPTION | - |
dc.subject.keywordPlus | VIVO | - |
dc.subject.keywordPlus | HALOFANTRINE | - |
dc.subject.keywordPlus | DISPERSION | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.